Jane S. Paulsen

Jane S. Paulsen's AcademicInfluence.com Rankings

Jane S. Paulsen

Biology

#9195

World Rank

#12368

Historical Rank

Neuroscience

#1327

World Rank

#1372

Historical Rank

biology Degrees

Download Badge

Biology

Jane S. Paulsen's Degrees

PhD Neuroscience University of California, Berkeley
Masters Psychology Stanford University

Why Is Jane S. Paulsen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jane S. Paulsen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Unified Huntington's disease rating scale: Reliability and consistency (1996) (1393)
Huntington disease: natural history, biomarkers and prospects for therapeutics (2014) (754)
A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length (2004) (745)
Detection of Huntington’s disease decades before diagnosis: the Predict-HD study (2007) (741)
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. (2004) (713)
Apathy is not depression. (1998) (626)
Is it possible to be schizophrenic yet neuropsychologically normal? (1997) (580)
Classifying neurocognitive disorders: the DSM-5 approach (2014) (485)
Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) (471)
Neuropsychiatric aspects of Huntington's disease (2001) (469)
Generalized cognitive deficits in schizophrenia: a study of first-episode patients. (1999) (467)
Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. (1995) (450)
Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease (2015) (420)
Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. (1994) (406)
Psychiatric Symptoms in Huntington’s Disease before Diagnosis: The Predict-HD Study (2007) (372)
Neurocognitive signs in prodromal Huntington disease. (2011) (357)
Rate of functional decline in Huntington’s disease (2000) (332)
CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches (2010) (309)
Preparing for preventive clinical trials: the Predict-HD study. (2006) (308)
Cognitive Impairment in Huntington Disease: Diagnosis and Treatment (2011) (291)
The nature of learning and memory impairments in schizophrenia (1995) (285)
Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. (1995) (281)
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion (2012) (263)
A comparison of category and letter fluency in Alzheimer's disease and Huntington's disease. (1994) (259)
fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease. (2004) (254)
Depression and stages of Huntington's disease. (2005) (247)
Memory in the Cerebral Cortex: An Empirical Approach to Neural Networks in the Human and Nonhuman Primate (1996) (247)
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset (2019) (236)
Longitudinal change in regional brain volumes in prodromal Huntington disease (2010) (231)
Brain Structure in Preclinical Huntington’s Disease (2006) (227)
Striatal and white matter predictors of estimated diagnosis for Huntington disease (2010) (224)
Incidence of and risk factors for hallucinations and delusions in patients with probable AD (2000) (216)
Critical periods of suicide risk in Huntington's disease. (2005) (212)
Clinical markers of early disease in persons near onset of Huntington’s disease (2001) (207)
Perceptions of genetic discrimination among people at risk for Huntington’s disease: a cross sectional survey (2009) (204)
Factor Analysis of the Frontal Systems Behavior Scale (FrSBe) (2003) (197)
An Assessment of the Semantic Network in Patients with Alzheimer's Disease (1993) (197)
Prediction of manifest Huntington's disease with clinical and imaging measures: a prospective observational study (2014) (195)
Capacity to provide informed consent for participation in schizophrenia and HIV research. (2002) (194)
Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease. (2007) (193)
Indexing disease progression at study entry with individuals at‐risk for Huntington disease (2011) (186)
Clinical and Biomarker Changes in Premanifest Huntington Disease Show Trial Feasibility: A Decade of the PREDICT-HD Study (2014) (184)
Dissociations within nondeclarative memory in Huntington's disease. (1996) (181)
Thalamic metabolism and symptom onset in preclinical Huntington's disease. (2007) (179)
"Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. (2010) (175)
Behavioural abnormalities contribute to functional decline in Huntington’s disease (2003) (172)
In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease (2004) (166)
Impairment of the semantic network in schizophrenia (1996) (163)
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease (2003) (161)
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. (2003) (155)
The relationship of neuropsychological abilities to specific domains of functional capacity in older schizophrenia patients (2003) (155)
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. (2016) (152)
Cerebral cortex structure in prodromal Huntington disease (2010) (143)
Practice effects in the prediction of long-term cognitive outcome in three patient samples: a novel prognostic index. (2007) (141)
Mild cognitive impairment in prediagnosed Huntington disease (2010) (137)
Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT‐HD study (2009) (136)
Clinical and neuropsychological comparison of psychotic depression with nonpsychotic depression and schizophrenia. (1996) (133)
Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities (2007) (128)
Schizoaffective disorder: a form of schizophrenia or affective disorder? (1999) (122)
Coercion and informed consent in research involving prisoners. (2004) (120)
Verbal episodic memory declines prior to diagnosis in Huntington's disease (2007) (119)
A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases (2013) (119)
Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment. (2011) (119)
Earliest functional declines in Huntington disease (2010) (117)
Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. (1998) (117)
fMRI detection of early neural dysfunction in preclinical Huntington's disease (2007) (115)
Classification of neurocognitive disorders in DSM-5: a work in progress. (2011) (110)
Preclinical Huntington's disease: Compensatory brain responses during learning (2006) (109)
Distinct cognitive profiles of cortical and subcortical dementia in advanced illness (1995) (106)
Practice effects predict cognitive outcome in amnestic mild cognitive impairment. (2011) (102)
Striatal Volume Contributes to the Prediction of Onset of Huntington Disease in Incident Cases (2012) (102)
Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults (2001) (102)
Patient and caregiver quality of life in Huntington's disease (2008) (100)
Nondementia nonpraecox dementia praecox? Late-onset schizophrenia. (1997) (100)
Functional imaging in Huntington's disease (2009) (100)
White Matter Volume and Cognitive Dysfunction in Early Huntington's Disease (2005) (98)
Longitudinal Psychiatric Symptoms in Prodromal Huntington's Disease: A Decade of Data. (2015) (96)
Neurocognitive deficits related to poor decision making in people behind bars (2008) (96)
Cognitive decline in prodromal Huntington Disease: implications for clinical trials (2013) (93)
The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory. (1999) (92)
Sensory- and memory-mediated olfactory dysfunction in Huntington's disease (1995) (91)
Network topology and functional connectivity disturbances precede the onset of Huntington's disease. (2015) (90)
Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. (1995) (89)
Cognitive domains that predict time to diagnosis in prodromal Huntington disease (2012) (89)
Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches (2007) (88)
Metabolic network as a progression biomarker of premanifest Huntington's disease. (2013) (87)
Blobs and front propagation in the scrape-off layer of magnetic confinement devices (2003) (86)
Fully automated analysis using BRAINS: AutoWorkup (2011) (86)
Ecological Validity of Neuropsychological and Personality Measures of Executive Functions (2001) (86)
Morphology of the cerebral cortex in preclinical Huntington's disease. (2007) (85)
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16 (2004) (84)
Suicidal ideation in Huntington disease: The role of comorbidity (2011) (84)
Self-paced timing detects and tracks change in prodromal Huntington disease. (2010) (84)
Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24: the HD MAPS study (2006) (83)
Commissioning of the Spherical Grating Monochromator Soft X-ray Spectroscopy Beamline at the Canadian Light Source (2007) (79)
Early Detection of Huntington Disease. (2010) (78)
Automatic detection of preclinical neurodegeneration (2009) (77)
Neuropsychological functioning pretreatment and posttreatment in an inpatient eating disorders program. (2003) (76)
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis (2010) (74)
The neuropathology of everyday life: The frequency of partial seizure symptoms among normals. (1990) (73)
Depression in the early stages of Huntington disease. (2011) (72)
Refining the diagnosis of Huntington disease: the PREDICT-HD study (2013) (71)
Measures of growth in children at risk for Huntington disease (2012) (70)
Short-term practice effects in amnestic mild cognitive impairment: implications for diagnosis and treatment (2008) (70)
Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression (2013) (70)
Challenges assessing clinical endpoints in early Huntington disease (2010) (69)
The emotional experiences of family carers in Huntington disease. (2009) (68)
MultiCenter Reliability of Diffusion Tensor Imaging (2012) (68)
Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis (2012) (67)
Cognitive and Psychiatric Aspects of Huntington Disease Contribute to Functional Capacity (2004) (67)
The effects of perceived versus enacted social support on the discriminative cue function of spouses for pain behaviors (1995) (66)
Comparison of the semantic networks in patients with dementia and amnesia. (1995) (65)
Odor detection, learning, and memory in Huntington's disease (1999) (65)
Evaluation of the GTRACT diffusion tensor tractography algorithm: A validation and reliability study (2006) (64)
Discrimination of cortical from subcortical dementias on the basis of memory and problem-solving tests. (1995) (64)
Managing juvenile Huntington's disease. (2013) (64)
Engagement with genetic discrimination: concerns and experiences in the context of Huntington disease (2008) (64)
Obsessive and compulsive symptoms in prediagnosed Huntington's disease. (2008) (63)
8OHdG as a marker for Huntington disease progression (2012) (62)
Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease. (2008) (61)
Traumatic Brain Injury in School-Age Children: Academic and Social Outcome. (2000) (61)
Neuropsychological Characteristics of Patients in a Hospital-Based Eating Disorder Program (2002) (60)
Relationship of neuropsychological and MRI measures to age of onset of schizophrenia a (1998) (60)
Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease (2013) (59)
Prism adaptation in Alzheimer's and Huntington's disease. (1993) (58)
Bioavailable Testosterone as a Correlate of Cognition, Psychological Status, Quality of Life, and Sexual Function in Aging Males: Implications for Testosterone Replacement Therapy (2001) (58)
Ischemic stress induces deposition of amyloid β immunoreactivity in human brain (2004) (58)
Neurobehaviors and psychotic symptoms in Alzheimer's disease (2000) (57)
Estimation of Premorbid Intelligence: The Word Accentuation Test - Buenos Aires Version (2000) (57)
Validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in individuals with Huntington disease (HD) (2015) (57)
Retrograde amnesia in dementia: comparison of HIV-associated dementia, Alzheimer's disease, and Huntington's disease. (2004) (56)
Predicting cognitive change in older adults: the relative contribution of practice effects. (2010) (56)
The Trail Making Test in prodromal Huntington disease: Contributions of disease progression to test performance (2011) (56)
Effects of depression on working memory in presymptomatic Huntington's disease. (2001) (55)
Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. (2013) (54)
Onset of Huntington's disease: Can it be purely cognitive? (2014) (54)
Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. (2016) (54)
Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study. (2013) (53)
Regression-based formulas for predicting change in RBANS subtests with older adults. (2005) (53)
Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease (2008) (53)
Frontal Behavioral Syndromes in Cortical and Subcortical Dementia (1996) (52)
Tracking motor impairments in the progression of Huntington's disease (2014) (51)
MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study (2017) (51)
Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias. (1995) (50)
Cognitive Reserve and Brain Reserve in Prodromal Huntington's Disease (2013) (49)
Perception, experience, and response to genetic discrimination in Huntington disease: The international RESPOND‐HD study (2010) (49)
Linking white matter and deep gray matter alterations in premanifest Huntington disease (2016) (49)
A test of odor fluency in patients with Alzheimer's and Huntington's disease. (1999) (49)
Electrophysiological insights into the nature of the semantic deficit in Alzheimer's disease (1996) (48)
Suicidal Behavior in Prodromal Huntington Disease (2011) (48)
Utility of a modified version of the wisconsin card sorting test in the detection of dementia of the alzheimer type. (1993) (48)
Caregiver burden in Huntington's disease. (2007) (47)
In their own words: Reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND‐HD study (2010) (47)
Depressive symptom severity is related to poorer cognitive performance in prodromal Huntington disease. (2012) (47)
Experiences of Teens Living in the Shadow of Huntington Disease (2008) (47)
Innervation of the cavernous body of the human efferent tear ducts and function in tear outflow mechanism (2000) (47)
Randomized Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington Disease (2009) (47)
Probability of Obsessive and Compulsive Symptoms in Huntington’s Disease (2007) (47)
Diffusion Tensor Imaging in Preclinical Huntington’s Disease (2009) (46)
Cognitive and behavioral changes in Huntington disease before diagnosis. (2017) (46)
Prefrontal cortex white matter tracts in prodromal Huntington disease (2015) (46)
Diffusion weighted imaging of prefrontal cortex in prodromal huntington's disease (2014) (45)
Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status (2010) (44)
Results of the citalopram to enhance cognition in Huntington disease trial (2014) (44)
Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin (2015) (44)
Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders (2001) (43)
Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status (2010) (43)
Family carer personal concerns in Huntington disease. (2011) (42)
Longitudinal diffusion changes in prodromal and early HD: Evidence of white‐matter tract deterioration (2017) (42)
HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD) (2016) (41)
Managing genetic discrimination: Strategies used by individuals found to have the Huntington disease mutation (2007) (40)
Huntington disease: families' experiences of healthcare services. (2010) (40)
An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers (2011) (39)
Traumatic Brain Injury in Children and Adolescents: Academic and Intellectual Outcomes Following Injury (2006) (39)
Neural bases of dysphoria in early Huntington's disease (2008) (39)
Comorbidities of Obsessive and Compulsive Symptoms in Huntington's Disease (2010) (39)
Dichotic listening and complex partial seizures. (1990) (39)
Predictors of diagnosis in Huntington disease (2007) (39)
Organized mucosa-associated lymphoid tissue in human nasolacrimal ducts. (2002) (38)
Practice effects and outcome of cognitive training: preliminary evidence from a memory training course. (2010) (37)
The power-proportion method for intracranial volume correction in volumetric imaging analysis (2014) (37)
Cognitive changes in Huntington's disease. (2005) (37)
WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease (2013) (37)
Executive function and magnetic resonance imaging subcortical hyperintensities in vascular dementia. (2001) (36)
“No one else sees the difference: ”family members' perceptions of changes in persons with preclinical Huntington disease (2007) (36)
Blood Vessel Function and Cognition in Elderly Patients With Atherosclerosis (2004) (36)
Dynamic functional network connectivity in Huntington's disease and its associations with motor and cognitive measures (2019) (36)
Validation of a prognostic index for Huntington's disease (2017) (35)
Confinement and bursty transport in a flux-driven convection model with sheared flows (2003) (35)
Cognitive Deficits and Psychopathology in Institutionalized versus Community-Dwelling Elderly Schizophrenia Patients (1999) (35)
Cognitive impairment in anorexia nervosa is not due to depressed mood. (2003) (35)
Neuropsychological and psychiatric functioning pre- and posthematopoietic stem cell transplantation in adult cancer patients: A preliminary study (2006) (34)
Unawareness of motor phenoconversion in Huntington disease (2013) (34)
Disruption of response inhibition circuits in prodromal Huntington disease (2014) (34)
A clinical and neuropsychological comparison of delusional disorder and schizophrenia. (1996) (33)
Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD (2015) (33)
Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task. (1998) (32)
New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system) (2016) (30)
Functional Connectivity of Primary Motor Cortex Is Dependent on Genetic Burden in Prodromal Huntington Disease (2014) (30)
Association between Age and Striatal Volume Stratified by CAG Repeat Length in Prodromal Huntington Disease (2011) (30)
Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease. (2018) (30)
Whole-Brain Connectivity in a Large Study of Huntington's Disease Gene Mutation Carriers and Healthy Controls (2018) (30)
Prism adaptation in schizophrenia (2006) (29)
Preliminary analysis using multi-atlas labeling algorithms for tracing longitudinal change (2015) (29)
Cross‐sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease (2016) (28)
Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase. (2018) (28)
Substance abuse may hasten motor onset of Huntington disease (2017) (27)
Anomalous Cross-Field Current and Fluctuating Equilibrium of Magnetized Plasmas (1997) (27)
Rating scales for cognition in Huntington's disease: Critique and recommendations (2018) (27)
Neuropsychological Performance Is Associated With Vascular Function in Patients With Atherosclerotic Vascular Disease (2007) (27)
Differentiating dementia from "pseudodementia" early in the clinical course: Utility of neuropsychological tests. (1992) (26)
Measuring executive dysfunction longitudinally and in relation to genetic burden, brain volumetrics, and depression in prodromal Huntington disease. (2012) (26)
Clinical predictors of driving status in Huntington's disease (2012) (26)
Perceived stress in prodromal Huntington disease (2012) (26)
Perception, experience, and response to genetic discrimination in Huntington's disease: the Australian results of The International RESPOND-HD study. (2013) (25)
The quasilinear behavior of convective turbulence with sheared flows (2003) (25)
Personal factors associated with reported benefits of Huntington disease family history or genetic testing. (2010) (25)
Mapping the order and pattern of brain structural MRI changes using change‐point analysis in premanifest Huntington's disease (2017) (25)
Neuropsychological impairment in Tardive dyskinesia. (1994) (24)
Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome (2016) (23)
Stability of neuropsychological performance in anorexia nervosa. (2008) (23)
Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington’s Disease Phenotype (2017) (21)
Patterns of serotonergic antidepressant usage in prodromal Huntington disease (2012) (21)
Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation (2016) (21)
Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest. (2011) (21)
Assessment of Depression, Anxiety and Apathy in Prodromal and Early Huntington Disease (2011) (21)
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington’s Disease (2019) (20)
Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study (1996) (20)
Detection of mild cognitive deficits in Parkinson's disease patients with the WAIS–R NI (2001) (19)
Assessment of Cognitive Symptoms in Prodromal and Early Huntington Disease (2011) (18)
Symptom validity test performance in the Huntington Disease Clinic. (2013) (18)
Couples’ Coping in Prodromal Huntington Disease: A Mixed Methods Study (2012) (18)
Factors associated with experiences of genetic discrimination among individuals at risk for huntington disease (2011) (17)
Estimating Premorbid IQ in the Prodromal Phase of a Neurodegenerative Disease (2011) (17)
Concordance between the CVLT and the WMS-III word lists test. (2004) (17)
Learning and memory in schizophrenia (1995) (17)
"Pre-symptomatic" Huntington's disease. (2008) (17)
The neuropsychological course of acute delirium in adult hematopoietic stem cell transplantation patients. (2011) (17)
Motor onset and diagnosis in Huntington disease using the diagnostic confidence level (2015) (16)
Everyday cognition in prodromal Huntington disease. (2015) (16)
Development of the Huntington Disease Family Concerns and Strategies Survey From Focus Group Data (2010) (16)
T1ρ imaging in premanifest Huntington disease reveals changes associated with disease progression (2015) (15)
Regional subcortical shape analysis in premanifest Huntington's disease (2018) (15)
Psychological well-being in persons affected by Huntington’s disease: A comparison of at-risk, prodromal, and symptomatic groups (2013) (15)
Couples’ Attributions for Work Function Changes in Prodromal Huntington Disease (2010) (15)
Bias in Estimation of a Mixture of Normal Distributions (2013) (15)
Movement sequencing in Huntington disease (2014) (14)
Self Reports of Day-to-Day Function in a Small Cohort of People with Prodromal and Early HD (2011) (14)
Robust Markers and Sample Sizes for Multicenter Trials of Huntington Disease (2020) (14)
Strategies used by teens growing up in families with Huntington disease. (2013) (14)
Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease. (2018) (13)
A Fully-Automated Subcortical and Ventricular Shape Generation Pipeline Preserving Smoothness and Anatomical Topology (2018) (13)
Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset (2022) (13)
Apathy Is Related to Cognitive Control and Striatum Volumes in Prodromal Huntington’s Disease (2019) (13)
Non-equilibrium quasi-stationary states in a magnetized plasma (2003) (13)
Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease. (2015) (12)
Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease (2015) (12)
Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease (2015) (12)
Assessment of Day-to-Day Functioning in Prodromal and Early Huntington Disease (2011) (12)
Diffeomorphic Shape Trajectories for Improved Longitudinal Segmentation and Statistics (2014) (12)
Efficient and Extensible Workflow: Reliable Whole Brain Segmentation for Large-Scale, Multi-center Longitudinal Human MRI Analysis Using High Performance/Throughput Computing Resources (2015) (12)
Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease. (2019) (11)
Dynamic Prediction of Motor Diagnosis in Huntington's Disease Using a Joint Modeling Approach. (2017) (11)
Tissue classification of large-scale multi-site MR data using fuzzy k-nearest neighbor method (2016) (10)
Sample enrichment for clinical trials to show delay of onset in huntington disease (2019) (10)
Biomarkers to predict and track diseases (2009) (10)
COHERENT STRUCTURES IN THE TURBULENT EQUILIBRIUM OF THE SIMPLE MAGNETIZED TORUS (1996) (10)
Assessment of Motor Symptoms and Functional Impact in Prodromal and Early Huntington Disease (2011) (9)
Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD) (2019) (9)
Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability? (2018) (9)
End-of-life measures in Huntington disease: HDQLIFE Meaning and Purpose, Concern with Death and Dying, and End of Life Planning (2019) (9)
Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures (2018) (9)
MRI subcortical segmentation in neurodegeneration with cascaded 3D CNNs (2021) (9)
Genetic load determines atrophy in hand cortico‐striatal pathways in presymptomatic Huntington's disease (2018) (9)
Genetic modifiers of Huntington's disease differentially influence motor and cognitive domains (2022) (8)
Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease (2016) (8)
Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD) (2020) (8)
Is There an Association of Physical Activity with Brain Volume, Behavior, and Day-to-day Functioning? A Cross Sectional Design in Prodromal and Early Huntington Disease (2016) (8)
Agreement between clinician-rated versus patient-reported outcomes in Huntington disease (2018) (8)
Meaning and purpose in Huntington’s disease: a longitudinal study of its impact on quality of life (2021) (8)
POSTER SESSIONS SCHEDULE (2013) (8)
Patient-Reported Outcome Measures in Huntington Disease: Quality of Life in Neurological Disorders (Neuro-QoL) Social Functioning Measures (2017) (8)
Generalizing MRI Subcortical Segmentation to Neurodegeneration (2020) (7)
MMPI profiles of patients who endorse multiple partial seizure symptoms. (1988) (7)
An Open-Source Label Atlas Correction Tool and Preliminary Results on Huntingtons Disease Whole-Brain MRI Atlases (2016) (7)
Factors influencing the clinical expression of intermediate CAG repeat length mutations of the Huntington’s disease gene (2014) (7)
Audio-visual reflex: determination of the audio-visual reflex in directional hearing by employment of electronystagmography. (1966) (7)
Genetics Modulate Gray Matter Variation Beyond Disease Burden in Prodromal Huntington’s Disease (2018) (6)
Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions" (2011) (6)
Development of the Huntington Disease Work Function Scale (2012) (6)
Phenotype Characterization of HD Intermediate Alleles in PREDICT-HD. (2016) (6)
Extending MCI beyond Alzheimer disease (2009) (6)
Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease (2021) (6)
Development of the HD-Teen Inventory (2012) (6)
Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden (2015) (6)
Predicting cognitive change within domains (2010) (5)
Mild Cognitive Impairment as an Early Landmark in Huntington's Disease (2021) (5)
Neurodegenerative disease: Establishing a clinical trial battery for Huntington disease (2012) (5)
The nature of the naming deficit in Alzheimer's disease suggests patients at-risk for psychosis (1999) (5)
Long-term psychiatric outcomes in adults with history of pediatric traumatic brain injury. (2021) (5)
Quality of Life in Prodromal HD: Qualitative Analyses of Discourse from Participants and Companions (2011) (4)
A study of the pressure and heat transfer distribution on highly swept slab delta wings in supersonic flow (1966) (4)
Behavior and Personality Disturbances (2008) (4)
Clinical Management of Aggression and Frontal Symptoms in Huntington’s Disease (2003) (4)
Crisis, Culture, and Response. (1988) (4)
Traumatic Brain Injury in Children and Adolescents: Psychiatric Disorders 24 Years Later. (2021) (4)
Early course of new-onset tardive dyskinesia in older patients. (1994) (4)
Candidates for Neurocognitive Markers in PRE-HD: Longitudinal Assessment From the PREDICT-HD COHORT (2008) (4)
Tensor-Based Grading: A Novel Patch-Based Grading Approach for the Analysis Of Deformation Fields in Huntington's Disease (2020) (3)
Bayesian covariate selection in mixed-effects models for longitudinal shape analysis (2016) (3)
The biasing effect of verbal labels on memory for ambiguous figures in patients with progressive dementia (1995) (3)
Vascular contributions to Alzheimer's disease. (2022) (3)
FAN1 nuclease activity affects CAG expansion and age at onset of Huntington’s disease (2021) (3)
Disease Progression in Huntington Disease: An Analysis of Multiple Longitudinal Outcomes. (2018) (3)
Understanding domains that influence perceived stigma in individuals with Huntington disease. (2020) (3)
Three-Field Model for Drift Waves in a Simple Magnetized Torus (2004) (3)
Clock drawing in schizophrenia: A qualitative analysis of impairment (1995) (3)
Frontal neuropsychiatric syndromes in Huntington's disease (HD) and Parkinson's disease (PD) (1999) (3)
Prediction of manifest Huntington disease with clinical and imaging measures: A 12-year prospective observational study (2020) (3)
The impact of oculomotor functioning on neuropsychological performance in Huntington disease (2016) (3)
Subject-specific longitudinal shape analysis by coupling spatiotemporal shape modeling with medial analysis (2017) (3)
How different aspects of motor dysfunction influence day‐to‐day function in huntington's disease (2019) (2)
Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group (2011) (2)
Does interval between screening and baseline matter in HD cognitive clinical trials? (2014) (2)
Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group (2011) (2)
Counseling Psychology and Neuropsychology (1992) (2)
Tracking Huntingtonʼs Disease Progression Using Motor, Functional, Cognitive, and Imaging Markers (2021) (2)
Poster 4: The Functional Rating Scale Taskforce for Pre-Huntington's Disease: An Empirically-Driven Initiative for New Scale Development (2009) (2)
Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes. (2019) (2)
Prism adaptation in schizophrenia (2003) (2)
Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease. (2017) (2)
Data quality assurance and control in cognitive research: Lessons learned from the PREDICT‐HD study (2017) (2)
The neuropsychology of aging (1994) (2)
Genetic overlap between psychiatric disorders and neuropsychiatric symptoms in HD (2019) (2)
Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease (2019) (2)
The utility of the Frontal Lobe Personality Scale (FLOPS) for characterizing behavior in Dementia of the Alzheimer's type (DAT) and Huntington's Disease (HD) (1996) (2)
The prevalence of specific cognitive impairments in schizophrenia (1997) (2)
Longitudinal subcortical segmentation with deep learning (2021) (2)
Investigation of forced turbulence and transport in toroidal magnetized plasmas (1998) (2)
Assessing Cognition in Movement Disorders (2003) (2)
The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study (2022) (2)
Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease. (2015) (2)
Assessment of Inattention and Executive Dysfunction in Early Huntington’s Disease: The Atomoxetine Pilot Trial (2008) (2)
Global and Regional Brain Morphology in Subjects with Huntington's Disease Prior to Diagnosis (2009) (1)
Concurrent Cross-Sectional and Longitudinal Analyses of Multivariate White Matter Profiles and Clinical Functioning in Pre-Diagnosis Huntington Disease. (2019) (1)
Poster 12: A Metabolic Network Associated with the Progression of Preclinical Huntington's Disease: Application of the Ordinal Trends Analysis to a Longitudinal PET Study (2009) (1)
Moderate Intensity Exercise in Pre-manifest Huntington’s Disease: Results of a 6 months Trial (2021) (1)
Poster 27: Characterizing Psychomotor Declines in Prodromal Huntington Disease with the Trail Making Test (2010) (1)
Poster 14: Earliest Functional Declines in Huntington's Disease (2009) (1)
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing (2022) (1)
Assessment of motor symptoms and functional impact in prodromal and early huntington disease. (2011) (1)
High and Low Levels of an NTRK2-Driven Genetic Profile Affect Motor- and Cognition-Associated Frontal Gray Matter in Prodromal Huntington’s Disease (2018) (1)
PREDICT-HD: Markers Identifying Individuals at Risk for Huntington Disease (2001) (1)
Impaired awareness in Huntington disease: medical evidence in relation to the optimal expectations model (2015) (1)
Chronic Illness and Close Relationships. (1997) (1)
The mattis dementia rating scale in older schizophrenia patients: Is there evidence of dementia? (1996) (1)
Deep learning models for brain imaging: model depth enhances discovery power (2014) (1)
Item Reduction of the University of Pennsylvania Smell Identification Test: Preparation for Clinical Trials in Pre-HD using the PREDICT-HD Cohort (2008) (1)
Understanding the need for assistance with survey completion in people with Huntington disease (2018) (1)
Analysis of longitudinal censored semicontinuous data with application to the study of executive dysfunction: The Towers Task (2017) (1)
Establishing a clinical trial battery for Huntington disease: Neurodegenerative disease (2012) (1)
Abnormal Structure of Cerebral White and Cortical Gray Matter in Preclinical Huntington’s Disease (2008) (1)
J25 Performance Of The 36-item And 12-item Whodas 2.0 In Prodromal Huntington Disease (2014) (1)
What Happens When HD Caregivers Seek Help (2011) (1)
Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1 (2021) (1)
Self-supervised Test-Time Adaptation for Medical Image Segmentation (2022) (1)
Practice effects and cognitive outcome in older adults with mild cognitive deficits (2005) (1)
Time-varying Hazards Model for Incorporating Irregularly Measured, High-Dimensional Biomarkers. (2020) (1)
Patch-Based Abnormality Maps for Improved Deep Learning-Based Classification of Huntington's Disease (2020) (1)
Anomalous Transport in the Simple Torus (2000) (1)
Neuropsychological studies in geriatric psychiatry (2003) (1)
Anomalous currents in laboratory and space plasmas (1997) (1)
G04 Brain structure in children at risk for Huntington's disease (2012) (1)
Longitudinal Change in Striatal Volume in Pre-Clinical Huntington's Disease (2009) (1)
Sixth Annual Huntington Disease Clinical Research Symposium (2012) (1)
Preliminary study of the association of white-matter metabolite concentrations with disease severity in patients with Huntington's disease. (2014) (1)
Defining cognitive domains and threshold (2010) (0)
FT-01-04 MAJOR NEUROCOGNITIVE DISORDER: CASE OF ALZHEIMER’S DISEASE (2010) (0)
I01 Unawareness of motor phenoconversion in huntington disease (2012) (0)
An investigation of functional connectivity in the inhibitory control network in Prodromal Huntington ' s Disease (2012) (0)
Longitudinal Decline in Negative Emotion Recognition Prior to Diagnosis in Huntington’s Disease (2008) (0)
Estimating premorbid functioning in elderly schizophrenic patients (1996) (0)
Third Annual Huntington Disease Clinical Research Symposium : Organized by the Huntington Study Group (Huntington Study Group Abstracts) (2010) (0)
Cross-Sectional Gender Comparison of Gray Matter Concentration in Prodromal Huntington’s Disease (2020) (0)
Platform Presentation—Loss of Striatal Dopaminergic Function and Thalamic Compensatory Mechanism During Phenocoversion of Preclinical Huntington's Disease (2009) (0)
Third Annual Huntington Disease Clinical Research Symposium : Organized by the Huntington Study Group (Huntington Study Group Abstracts) (2010) (0)
Poster 5: An Item Response Analysis of Depressive Symptomatology in Pre-Huntington Disease (2009) (0)
Early detection of dementia in Huntington’s disease: The Predict-HD study (2005) (0)
A07 Critical consideration of the criteria for the motor diagnosis of huntington disease (2012) (0)
E01 CAG Repeat Length Predicts Rate of Striatal Atrophy, but Relationship is Nonlinear (2014) (0)
Learning impairment in older schizophrenia patients with intact attention (1997) (0)
H06 Longitudinal Psychiatric Symptoms in Premanifest HD: Psychiatric Progression and Unawareness in a Decade of Data (2014) (0)
Index to Authors/Keywords/Titles and Volume Contents (1996) (0)
F09 Progression of motor symptoms prior to diagnosis in HD-gene carriers (2010) (0)
J01 Improving Prediction Of Huntington Disease Onset With Clinical And Imaging Measures: A 10-year Preopective Study Of Converters (2014) (0)
Poster 18: Lack of Awareness of Motor and Cognitive Phenoconversion in Huntington's Disease (2010) (0)
Brain Correlates of Neuropsychological Function in Presymptomatic HD Gene Carriers (2008) (0)
Death Anxiety in Huntington Disease: Longitudinal Heath-Related Quality-of-Life Outcomes. (2023) (0)
A26 Cognitive and behavioural changes in prodromal and diagnosed hd (2016) (0)
HDQLIFE Concern With Death and Dying Scale (2018) (0)
Changes in cognition in Huntington’s disease and its relationship to future cognition (2005) (0)
Predicting an optimal composite outcome variable for Huntington's disease clinical trials (2020) (0)
Neurobehavioral frontal dysfunction in Alzheimer's disease with and without psychosis (1999) (0)
A Model of the Extent and Impact of Inter-Rater Variability for the UHDRS Motor and Diagnostic Confidence Scales (2008) (0)
Comprehensive shape analysis of the cortex in Huntington's disease (2022) (0)
Detecting preclinical neurodegeneration: An example from Huntington's disease (2009) (0)
A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington’s Disease (2021) (0)
Poster 11: Motor Symptom–Related Metabolic Network in Huntington's Disease (2009) (0)
Test-Retest Reliability and Prospective Validation of an Abnormal Metabolic Network of Premanifest Huntington's Disease (S20.001) (2013) (0)
Poster 11: Striatal Volume Distinguishes Converters from Non-Converters: Findings from PREDICT-HD (2010) (0)
Poster 10: A Randomized, Controlled Trial of Atomoxetine for Cognitive Dysfunction in Early Huntington's Disease (2009) (0)
Controlling for Individual Differences in Neurocognitive Markers in Pre-Diagnosis HD in the PREDICT-HD Cohort (2008) (0)
HDQLIFE Meaning and Purpose Scale (2018) (0)
Subtle Motor Abnormalities in Pre-Manifest HD Are Associated With Gene Status, Probability of Disease Onset, and Striatal Atrophy (2008) (0)
Poster 15: Predicting Cognitive Decline: Another Method for Stratifying Samples? (2009) (0)
Substance Abuse Hastens Age of Onset of Huntington Disease: Evaluating the Enroll-HD Database (2016) (0)
Test-retest reproducibility of a progression-related pattern (HDPP) in premanifest Huntington's disease: A multicenter pilot study with FDG PET (2012) (0)
Platform presentation—Late-breaking research—Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study (2010) (0)
H01 Prospective diagnosis of huntington disease: prognostic indicators and directions for future study (2012) (0)
[Of what use is sonography in orthopedics?]. (1989) (0)
J02 What are the best cognitive tests for clinical trials? the devil is in the details (2012) (0)
Understanding brain-behavior relations. (1998) (0)
Huntington Disease (2019) (0)
K01 Behaviour assessments in children at risk for huntington's disease (2012) (0)
E17 Diffusion Weighted Imaging Study Of Prefrontal Cortex White Matter In Prodromal Huntington Disease (2014) (0)
Use of the pressure transients in the method of kulbrinteindvending (2011) (0)
Magneto-Inertial Confinement of Turbulent Plasma (1995) (0)
Poster Session I (1997) (0)
Impaired startle gating in Huntington's disease: Neuropsychological correlates (1994) (0)
Understanding the Simple Magnetized Torus (2003) (0)
Clock drawing and psychosis in Alzheimer's disease (1999) (0)
Assessing anger and irritability prior to clinical diagnosis of Huntington's disease: the functional rating scale taskforce for pre-Huntington's disease (2009) (0)
Gender and schizophrenia. (2009) (0)
Use of the MMPI to predict maintenance of treatment gains in chronic pain patients: A longitudinal study (1990) (0)
Treatment of HD: A Survey of HD Clinicians (2008) (0)
F10 Quantifying putative biomarkers of Huntington disease in blood and urine by selected reaction monitoring mass spectrometry (2012) (0)
Basal Ganglia Circuit integrity Assessed in Working Memory in Huntington's Disease (2009) (0)
Third Annual Huntington Disease Clinical Research Symposium (2011) (0)
Third Annual Huntington Disease Clinical Research Symposium (2011) (0)
Poster 29: Multivariate Clinical Predictors of Huntington Disease (HD): Prospective Results from the PREDICT-HD Study (2010) (0)
L07 The functional rating taskforce for pre-huntington's disease: development of the furst-21 scale (2012) (0)
Evaluation of Multi-Center Diffusion Tensor Imaging (2009) (0)
Cerebral Cortex Morphology in Subjects with Huntington's Disease Prior to Diagnosis (2009) (0)
Second Annual Huntington Disease Clinical Research Symposium (2011) (0)
Second Annual Huntington Disease Clinical Research Symposium (2011) (0)
Care/Health Services (2009) (0)
Huntington's disease introduction to diagnosis, genetics, and management (slide library) (1996) (0)
Contents Vol. 8, 2011 (2011) (0)
Factors Associated with the Place of Death in Huntington Disease: Analysis of Enroll-HD. (2023) (0)
PSYCHOTIC DEPRESSION. AUTHORS' REPLY (1997) (0)
Human brain extraction with deep learning (2022) (0)
I35 Substance abuse leads to earlier age of onset of huntington’s disease: an epidemiological study of the Enroll-HD database (2016) (0)
Validity of automated versus standard forms of the Wisconsin card sorting test in psychiatric patients (1997) (0)
Field Testing of the Hd Teen Survey: Initial Findings (2011) (0)
Implicit and Explicit Memory: Contributions From Anesthesia. (1995) (0)
I02 Effect of CAG length on motor scores of children at risk for huntington's disease (2012) (0)
38. Maintenance treatment in older schizophrenics (1996) (0)
HD Family Teen Data Analysis Using a Developmental Lens (2011) (0)
Verbal working memory performance in older Schizophrenia patients (1998) (0)
Platform Presentation—Longitudinal Structural MRI Data from PREDICT-HD: Striatal and Cortical Changes in Pre-Clinical HD (2009) (0)
Poster 24: Worry and Experience of Genetic Discrimination in Persons at Risk for Huntington Disease (2010) (0)
Perceived Stigma Negatively Affects Social Participation and Satisfaction Among Individuals With Huntington Disease (2016) (0)
Poster 16: Antidepressant Use in PREDICT-HD: Patterns of Use Relevant to “Naturalistic” Drug Studies (2009) (0)
Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1 (2022) (0)
Huntington Disease-Teen Inventory (2014) (0)
Reader Response: Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease (2022) (0)
Juvenile Onset Huntington's Disease (2021) (0)
F08 The functional rating taskforce for pre-huntington's disease: results so far (2010) (0)
H03 Rate of progression is associated with age of disease onset for all HD (2012) (0)
F13 Progressive reduction of plasma 24S-hydroxycholestrol in prodromal HD subjects according with clinical and MRI features in the PREDICT-HD study (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jane S. Paulsen?

Jane S. Paulsen is affiliated with the following schools:

University of California, Berkeley
California Institute of Technology
Stanford University
University of Iowa